Filing Details
- Accession Number:
- 0001213900-18-017210
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-11 16:21:19
- Reporting Period:
- 2018-12-11
- Accepted Time:
- 2018-12-11 16:21:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1553643 | Relmada Therapeutics Inc. | RLMD | Pharmaceutical Preparations (2834) | 455401931 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1658544 | Edward Paul Kelly | C/O Relmada Therapeutics, Inc. 750 Third Avenue, 9Th Floor New York, NY 10016 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-11 | 5,000 | $1.21 | 388,483 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
